EDETOX logo

IN VIVO STUDIES FURTHER DETAILS


BACK TO THE MAIN MENU

back to previous page forward to next page

University of Newcastle homepage

In Vivo Study No: 308

METHODS

ChemicalMembraneConcentration mg/mlConcentration mg/mlloading (mg/cm2)SpeciesSiteArea (cm2)Occluded?Exposure Time (h)Analytical Method
2,4 Dimethylamine0.19.7230.2315Commercial Formulation Wilbur-EllisRatMid-dorsal4.2224Radiolabelled (14C)

RESULTS

Length of Study (h)% Recovery+/-Dose remaining on surface (mg)% remaining on SurfaceDose remaining in stratum corneum (mg)% remaining in stratum corneumDose remaining in the viable skin% remaining in the viable skinAmount Absorbed (mg)% Absorbed+/-% Absorbed
168106.22.950.88190.6  0.05860.151715.65.6315.6
Maximal Flux (mcrg/cm2/h)Average Flux (mcrg/cm2/h)+/-Time Plasma/Blood Levels Peaked (h)Peak Blood Concentration (mg/l)nkp (cm/h)Lag Time (h)
     4  

NOTES

Sprague-Dawley Rats were used. The % absorption was determined from the amounts found in the urine + faeces + tissue. A non-occclusive foam rubber skin patch was used to protect the site of application.

REFERENCE

In Vitro Dermal Absorption Of Two Commercial Formulations Of 2,4-Dichlorophenoxyacetic Acid Dimethylamine (2,4-D Amine) in Rat, Guinea Pig and Human Skin (1997) Toxicol. Vitro, 11 :251-262